Literature DB >> 9003632

Comparison of PCR and hybrid capture methods for detection of human papillomavirus in injection drug-using women at high risk of human immunodeficiency virus infection.

K V Shah1, L Solomon, R Daniel, S Cohn, D Vlahov.   

Abstract

We compared Hybrid Capture, a new technique for detection of human papillomaviruses (HPV), with a PCR assay based on L1 consensus primers. By both methods, the HPV prevalence was higher in human immunodeficiency virus (HIV)-positive women than in HIV-negative women. PCR had a higher sensitivity (0.89 versus 0.48) but lower specificity (0.43 versus 0.93) for detection of Pap smear abnormalities, compared to Hybrid Capture. The higher intensity of hybridization signal by PCR was related to higher estimates of viral load by Hybrid Capture.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9003632      PMCID: PMC229616          DOI: 10.1128/jcm.35.2.517-519.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

Review 1.  Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: possible implications for cervical cancer screening.

Authors:  C J Meijer; A J van den Brule; P J Snijders; T Helmerhorst; P Kenemans; J M Walboomers
Journal:  IARC Sci Publ       Date:  1992

2.  The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants.

Authors:  D Vlahov; J C Anthony; A Munoz; J Margolick; K E Nelson; D D Celentano; L Solomon; B F Polk
Journal:  NIDA Res Monogr       Date:  1991

3.  Human immunodeficiency virus-induced immunosuppression: a risk factor for human papillomavirus infection.

Authors:  R Matorras; J M Ariceta; A Rementeria; J Corral; G Gutierrez de Terán; J Diez; F Montoya; F J Rodriguez-Escudero
Journal:  Am J Obstet Gynecol       Date:  1991-01       Impact factor: 8.661

4.  Persistence of type-specific human papillomavirus infection among cytologically normal women.

Authors:  A Hildesheim; M H Schiffman; P E Gravitt; A G Glass; C E Greer; T Zhang; D R Scott; B B Rush; P Lawler; M E Sherman
Journal:  J Infect Dis       Date:  1994-02       Impact factor: 5.226

5.  Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for human immunodeficiency virus infection.

Authors:  R S Klein; G Y Ho; S H Vermund; I Fleming; R D Burk
Journal:  J Infect Dis       Date:  1994-12       Impact factor: 5.226

6.  Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance.

Authors:  J T Cox; A T Lorincz; M H Schiffman; M E Sherman; A Cullen; R J Kurman
Journal:  Am J Obstet Gynecol       Date:  1995-03       Impact factor: 8.661

7.  An evaluation of human papillomavirus testing for intermediate- and high-risk types as triage before colposcopy.

Authors:  K D Hatch; A Schneider; M W Abdel-Nour
Journal:  Am J Obstet Gynecol       Date:  1995-04       Impact factor: 8.661

8.  Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities.

Authors:  T C Wright; X W Sun; J Koulos
Journal:  Obstet Gynecol       Date:  1995-02       Impact factor: 7.661

9.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Authors:  F X Bosch; M M Manos; N Muñoz; M Sherman; A M Jansen; J Peto; M H Schiffman; V Moreno; R Kurman; K V Shah
Journal:  J Natl Cancer Inst       Date:  1995-06-07       Impact factor: 13.506

10.  Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md.

Authors:  K E Nelson; D Vlahov; L Solomon; S Cohn; A Muñoz
Journal:  Arch Intern Med       Date:  1995-06-26
View more
  7 in total

1.  Determinants of newly detected human papillomavirus infection in HIV-infected and HIV-uninfected injection drug using women.

Authors:  Darcy F Phelan; Stephen J Gange; Linda Ahdieh-Grant; Shruti H Mehta; Gregory D Kirk; Keerti Shah; Patti Gravitt
Journal:  Sex Transm Dis       Date:  2009-03       Impact factor: 2.830

2.  Comparative evaluation of first- and second-generation digene hybrid capture assays for detection of human papillomaviruses associated with high or intermediate risk for cervical cancer.

Authors:  M Poljak; A Brencic; K Seme; A Vince; I J Marin
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

3.  Human papillomavirus type 16 viral load is higher in human immunodeficiency virus-seropositive women with high-grade squamous intraepithelial lesions than in those with normal cytology smears.

Authors:  Jonas Lefevre; Catherine Hankins; Deborah Money; Anita Rachlis; Karina Pourreaux; François Coutlée
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

4.  Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group.

Authors:  C Hankins; F Coutlée; N Lapointe; P Simard; T Tran; J Samson; L Hum
Journal:  CMAJ       Date:  1999-01-26       Impact factor: 8.262

5.  Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies.

Authors:  C L Peyton; M Schiffman; A T Lörincz; W C Hunt; I Mielzynska; C Bratti; S Eaton; A Hildesheim; L A Morera; A C Rodriguez; R Herrero; M E Sherman; C M Wheeler
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

6.  Prevalence and Risk Factors Associated with Precancerous Cervical Cancer Lesions among HIV-Infected Women in Resource-Limited Settings.

Authors:  Peter Memiah; Wangeci Mbuthia; Grace Kiiru; Solomon Agbor; Francesca Odhiambo; Sylvia Ojoo; Sibhatu Biadgilign
Journal:  AIDS Res Treat       Date:  2012-04-04

7.  Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia.

Authors:  V V Sahasrabuddhe; M H Mwanahamuntu; S H Vermund; W K Huh; M D Lyon; J S A Stringer; G P Parham
Journal:  Br J Cancer       Date:  2007-04-17       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.